Two scientists walk into a bar and announce: “We have found the secret of life.” Arrogant? Maybe. But in 1953 when Watson and Crick walked into the Eagle Pub in Cambridge after a long day in the Cavendish Lab and made that claim, few could argue that they were on to something.
Discovering the double helix structure of DNA was a pretty big deal.
The field of genetic analysis continues to evolve (fast!) as the number of different technologies and their possible applications expand. The challenge for suppliers is identifying gaps, forecasting technologies and keeping up with the Joneses.
To help suppliers, we’ve done an extensive study on genomics technologies that projects planned expenditures, estimates market share, identifies unmet needs and reveals how well major suppliers are performing.
Genomic Technologies: Market Insights for Life Science Suppliers was designed to quantify and characterize the market for genetic analysis products, including those for genome-wide association studies (GWAS), copy number variation (CNV) analysis, genotyping and techniques such as microarrays, sequencing and real-time PCR.
For this primary research report, we surveyed 473 scientists worldwide who conduct genetic analysis in their research.
The questionnaire consisted of 24 closed or partially close-ended questions and 18 open-ended questions designed to help you find out what you need to know. I’ll send you the survey questions if you want to have a look—you can reach me at [email protected].
And here’s a sneak preview for you.
When asked: Where in your genetic analysis workflow do you feel DNA sequencing is the most valuable (e.g., validating data, generating hypotheses, etc.)?
220 scientists indicated the following: